Immunic Doubles Down On Lead Asset With New Data In Ulcerative Colitis

 
• By Jessica Merrill
  
two roads
Immunic is exploring several paths forward for vidofludimus calcium • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D